The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
NCT04593563
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
Psilocybin
Sponsor
Maryland Oncology Hematology, PA